Brooklyn, NY, United States of America

Adam Hilborn

This inventor holds 6 USPTO granted patents. Top assignee: Gilead Sciences, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Hilborn. Retrieved from https://idiyas.com/inventor/adam-hilborn-p3wmbzrw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 83.3

Average Co-Inventor Count = 18.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Adam Hilborn

Introduction

Adam Hilborn is a notable inventor based in Brooklyn, NY. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work is characterized by a commitment to innovation and improvement in product design.

Latest Patents

One of Adam's latest patents is a pharmaceutical package, which showcases his dedication to enhancing the safety and efficacy of medication delivery. This invention reflects his understanding of the complexities involved in pharmaceutical packaging and the importance of user-friendly designs.

Career Highlights

Adam is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role there allows him to work on cutting-edge projects that aim to improve health outcomes for patients worldwide. His expertise and innovative mindset have made him a valuable asset to the company.

Collaborations

Adam has collaborated with talented coworkers such as Benjamin Luke Kozub and Brian Nilstoft. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

In summary, Adam Hilborn is an accomplished inventor whose work in pharmaceutical packaging exemplifies his innovative spirit. His contributions to Gilead Sciences, Inc. and collaborations with fellow inventors highlight his commitment to advancing the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…